Stanley Druckenmiller is Loading Up on These 5 Stocks

3. Moderna, Inc. (NASDAQ: MRNA)

Number of Hedge Fund Holders: 37 

Moderna, Inc. (NASDAQ: MRNA) is a Cambridge-based biotechnology company. It is placed third on our list of 15 stocks Stanley Druckenmiller is loading up on. Latest data shows that Duquesne Capital owned 222,400 shares in Moderna, Inc. (NASDAQ: MRNA) at the end of the second quarter of 2021 worth $52.2 million, representing 1.5% of the portfolio. 

On July 15, investment advisory Jefferies kept a Hold rating on Moderna, Inc. (NASDAQ: MRNA) stock but raised the price target to $250 from $170, noting that the advisory expected the revenue guidance for the company to increase for the year. 

At the end of the second quarter of 2021, 37 hedge funds in the database of Insider Monkey held stakes worth $5.7 billion in Moderna, Inc. (NASDAQ: MRNA), down from 39 in the preceding quarter worth $1.6 billion. 

In its Q2 2021 investor letter, Baillie Gifford, an asset management firm, highlighted a few stocks and Moderna, Inc. (NASDAQ: MRNA) was one of them. Here is what the fund said:

“Among the top contributors to Fund performance in the second quarter was Moderna. Moderna has just reported its first profitable quarter in the company’s history – net income for the most recent quarter was $1.2 billion. It reported revenue of $1.9 billion, an impressive increase compared to $8 million a year ago, driven by the sales of its Covid-19 vaccine. Moderna is expecting to deliver up to 1 billion vaccine doses in 2021 and is in discussions to increase global supply to governments around the world. Our long-term focus remains on the transformational potential of Moderna’s technology and its ability to address different diseases.”